Your browser doesn't support javascript.
loading
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis.
Palandri, Francesca; Breccia, Massimo; Bonifacio, Massimiliano; Polverelli, Nicola; Elli, Elena M; Benevolo, Giulia; Tiribelli, Mario; Abruzzese, Elisabetta; Iurlo, Alessandra; Heidel, Florian H; Bergamaschi, Micaela; Tieghi, Alessia; Crugnola, Monica; Cavazzini, Francesco; Binotto, Gianni; Isidori, Alessandro; Sgherza, Nicola; Bosi, Costanza; Martino, Bruno; Latagliata, Roberto; Auteri, Giuseppe; Scaffidi, Luigi; Griguolo, Davide; Trawinska, Malgorzata; Cattaneo, Daniele; Catani, Lucia; Krampera, Mauro; Lemoli, Roberto M; Cuneo, Antonio; Semenzato, Gianpietro; Foà, Robin; Di Raimondo, Francesco; Bartoletti, Daniela; Cavo, Michele; Palumbo, Giuseppe A; Vianelli, Nicola.
  • Palandri F; Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi University Hospital, Bologna, Italy.
  • Breccia M; Division of Cellular Biotechnology and Hematology, Sapienza University, Rome, Italy.
  • Bonifacio M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Polverelli N; Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST-Spedali Civili di Brescia, Brescia, Italy.
  • Elli EM; Hematology Division and Bone Marrow Unit, San Gerardo Hospital, Monza, Italy.
  • Benevolo G; Division of Hematology, City Hospital of Health and Science, Turin, Italy.
  • Tiribelli M; Division of Hematology and Bone Marrow Transplantation, Integrated Healthcare University of Udine, Udine, Italy.
  • Abruzzese E; Division of Hematology, St Eugene Hospital, Rome, Italy.
  • Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy.
  • Heidel FH; Internal Medicine II, Hematology and Oncology, Friedrich Schiller University Medical Center, Jena, Germany.
  • Bergamaschi M; Clinic of Hematology, Department of Internal Medicine, IRCCS San Martino Hospital, University of Genoa, Genoa, Italy.
  • Tieghi A; Hematology Unit, Azienda Unità Sanitaria Locale - IRCCS, Arcispedale S.Maria Nuova, Reggio Emilia, Italy.
  • Crugnola M; Division of Hematology, University Hospital of Parma, Parma, Italy.
  • Cavazzini F; Division of Hematology, University of Ferrara, Ferrara, Italy.
  • Binotto G; Unit of Hematology and Clinical Immunology, University of Padua, Padua, Italy.
  • Isidori A; Hematology and Stem Cell Transplantation Center, Azienda Ospedaliera Ospedali Riuniti Marche Nord (AORMN), Pesaro, Italy.
  • Sgherza N; Division of Hematology, Home for the Relief of Suffering, San Giovanni Rotondo, Italy.
  • Bosi C; Division of Hematology, Local Healthcare Unit of Piacenza, Piacenza, Italy.
  • Martino B; Division of Hematology, "Bianchi Melacrino Morelli" Hospital Corporation, Reggio Calabria, Italy.
  • Latagliata R; Division of Cellular Biotechnology and Hematology, Sapienza University, Rome, Italy.
  • Auteri G; Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi University Hospital, Bologna, Italy.
  • Scaffidi L; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Griguolo D; Division of Hematology and Bone Marrow Transplantation, Integrated Healthcare University of Udine, Udine, Italy.
  • Trawinska M; Division of Hematology, St Eugene Hospital, Rome, Italy.
  • Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy.
  • Catani L; Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi University Hospital, Bologna, Italy.
  • Krampera M; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Lemoli RM; Clinic of Hematology, Department of Internal Medicine, IRCCS San Martino Hospital, University of Genoa, Genoa, Italy.
  • Cuneo A; Division of Hematology, University of Ferrara, Ferrara, Italy.
  • Semenzato G; Unit of Hematology and Clinical Immunology, University of Padua, Padua, Italy.
  • Foà R; Division of Cellular Biotechnology and Hematology, Sapienza University, Rome, Italy.
  • Di Raimondo F; Division of Hematology, V. Emanuele University Polyclinic, University of Catania, Catania, Italy.
  • Bartoletti D; Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi University Hospital, Bologna, Italy.
  • Cavo M; Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi University Hospital, Bologna, Italy.
  • Palumbo GA; Department of Medical Science, Surgery, and Advanced Technology "G. F. Ingrassia", University of Catania, Catania, Italy.
  • Vianelli N; Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi University Hospital, Bologna, Italy.
Cancer ; 126(6): 1243-1252, 2020 03 15.
Article en En | MEDLINE | ID: mdl-31860137
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Privación de Tratamiento / Mielofibrosis Primaria Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Privación de Tratamiento / Mielofibrosis Primaria Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article